Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- lutetium lu 177 dotatate
- Vaxchora (cholera vaccine, live)
Interactions between your drugs
cholera vaccine, live lutetium Lu 177 dotatate
Applies to: Vaxchora (cholera vaccine, live), lutetium lu 177 dotatate
If you are currently being treated or have recently been treated with lutetium Lu 177 dotatate, you should let your doctor know before receiving cholera vaccine, live. The use of cholera vaccine, live has not been adequately studied in patients receiving medications that affect the immune system, and it is not known whether you may have an increased risk of side effects or a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of lutetium Lu 177 dotatate therapy. If you have recently been vaccinated with cholera vaccine, live, your doctor may choose to postpone treatment with lutetium Lu 177 dotatate for a couple of weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
cholera vaccine, live food/lifestyle
Applies to: Vaxchora (cholera vaccine, live)
Administration of cholera vaccine, live with food or drink may reduce its effectiveness. Avoid eating or drinking for 60 minutes before and after taking cholera vaccine, live.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Cometriq
Cometriq (cabozantinib) is used to treat thyroid cancer that has spread to other parts of the body ...
Zortress
Zortress (everolimus) is used to prevent organ rejection in adult kidney transplant recipients ...
Cabozantinib
Cabozantinib is used for hepatocellular carcinoma, neuroendocrine tumors, renal cell carcinoma ...
Lanreotide
Lanreotide (Somatuline Depot) is an injectable medication containing a man-made (synthetic ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.